Not a Member? Register Now
Email this page
Send the page "" to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
FDA Date: 03/27/2014
Zyban (bupropion hydrochloride) Sustained-Release Tablets REMS
Goals of the Zyban (bupropion hydrochloride) Sustained-Release Tablets REMS Program
The goal of this REMS is to inform patients about the potential serious risk of neuropsychiatric adverse events associated with the use of ZYBAN.
• Medication Guide